Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ikena Oncology (IKNA) just unveiled an update.
Ikena Oncology, Inc. has elevated Jotin Marango, M.D., Ph.D. to the role of Chief Operating Officer while he retains his positions as Chief Financial Officer and Head of Corporate Development. Dr. Marango brings a wealth of experience from previous high-level roles in biotech firms and equity research, with a strong background in oncology. His promotion includes a salary increase to $470,000 and an option for 400,000 shares, contingent on a strategic company transaction and ongoing service. Dr. Marango’s appointment is based solely on his professional qualifications, with no familial ties to the company’s leadership.
See more insights into IKNA stock on TipRanks’ Stock Analysis page.
